Current Opinion in Drug Discovery & Development | Most viewed articles in past year

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central

Quick Search

	Current Opinion in Drug Discovery & Development
	BioMed Central
	PubMed Central
	PubMed

Jump to article


vol.	page no.

Current Opinion in Drug Discovery & Development

Most viewed

Current Opinion in Drug Discovery & Development: Most viewed articles in past year

[more info]

Figures given indicate the abstract, full text and PDF accesses on BioMed Central for each article, over the last year. All research articles are also available via the PubMed Central archive, so the total number of accesses to each article is significantly higher. Lists of most-viewed articles over the last 30 days and of all time most-viewed articles are also available

most viewed articles over the last year from all BioMed Central Journals

1. Accesses 681	Review Tuning out of hERG AM Aronov Current Opinion in Drug Discovery and Development 2008, 11:128-140 (20December2007) [PDF] [PubMed] [Related articles]
2. Accesses 594	Review Minimizing metabolic activation during pharmaceutical lead optimization: Progress, knowledge gaps and future directions S Kumar, K Kassahun, RA Tschirret-Guth, K Mitra, TA Baillie Current Opinion in Drug Discovery and Development 2008, 11:43-52 (20December2007) [PDF] [PubMed] [Related articles]
3. Accesses 554	Review Small-molecule inhibitors of protein-protein interactions T Berg Current Opinion in Drug Discovery and Development 2008, 11:666-674 (22August2008) [PDF]
4. Accesses 515	Review Drug-induced hepatotoxicity in humans Marzio D Halegoua-De, VJ Navarro Current Opinion in Drug Discovery and Development 2008, 11:53-59 (20December2007) [PDF] [PubMed] [Related articles]
5. Accesses 502	Review The sulfonamide group as a structural alert: A distorted story? DA Smith, RM Jones Current Opinion in Drug Discovery and Development 2008, 11:72-79 (20December2007) [PDF] [PubMed] [Related articles]
6. Accesses 432	Review Delivering silence: Advancements in developing siRNA therapeutics TI Novobrantseva, A Akinc, A Borodovsky, Fougerolles A de Current Opinion in Drug Discovery and Development 2008, 11:217-224 (15February2008) [PDF] [PubMed] [Related articles]
7. Accesses 420	Review Positron emission tomography for use in microdosing studies C C Wagner, M Mller, G Lappin, O Langer Current Opinion in Drug Discovery and Development 2008, 11:104-110 (20December2007) [PDF] [PubMed] [Related articles]
8. Accesses 415	Review mGluR5 antagonists: Discovery, characterization and drug development F Gasparini, G Bilbe, B Gomez-Mancilla, W Spooren Current Opinion in Drug Discovery and Development 2008, 11:655-665 (22August2008) [PDF]
9. Accesses 402	Review Antibody therapeutics, antibody engineering, and the merits of protein stability SJ Demarest, SM Glaser Current Opinion in Drug Discovery and Development 2008, 11:675-687 (22August2008) [PDF]
10. Accesses 400	Review From the bench to the bedside: Dipeptidyl peptidase IV inhibitors, a new class of oral antihyperglycemic agents Z Pei Current Opinion in Drug Discovery and Development 2008, 11:512-532 (30June2008) [PDF] [PubMed] [Related articles]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us